{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:32:42Z","timestamp":1761561162584},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1007\/s11926-001-0066-6","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T12:11:24Z","timestamp":1180786284000},"page":"513-519","source":"Crossref","is-referenced-by-count":11,"title":["Treatment of chronic pain in osteoarthritis: Do opioids have a clinical role?"],"prefix":"10.1007","volume":"3","author":[{"given":"Arthur G.","family":"Lipman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"66_CR1","volume-title":"Clinical practice guideline. AHCPR Publication Number 92-0032","author":"Acute Pain Management Guideline Panel","year":"1992","unstructured":"Acute Pain Management Guideline Panel: Acute pain management: operative or medical procedures and trauma. In Clinical practice guideline. AHCPR Publication Number 92-0032. Rockville, MD: Agency for Health Care Policy and Research, U.S. Department of Health and Human Services; 1992."},{"key":"66_CR2","volume-title":"Principles of Analgesic Use in the Treatment of Acute Pain and Chronic Cancer Pain","author":"American Pain Society","year":"1999","unstructured":"American Pain Society: Principles of Analgesic Use in the Treatment of Acute Pain and Chronic Cancer Pain, edn 4. Glenview, IL: American Pain Society; 1999.","edition":"edn 4"},{"key":"66_CR3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0749-0690(18)30214-3","volume":"12","author":"AG Lipman","year":"1996","unstructured":"Lipman AG: Analgesic drugs for neuropathic and sympathetically maintained pain. Clin Geriatr Med 1996, 12:501\u2013515.","journal-title":"Clin Geriatr Med"},{"key":"66_CR4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0885-3924(87)80044-1","volume":"2","author":"National Institutes of Health","year":"1987","unstructured":"National Institutes of Health: National Institutes of Health Consensus Development Conference: the integrated approach to the management of pain. J Pain Symptom Manage 1987, 2:35\u201344.","journal-title":"J Pain Symptom Manage"},{"key":"66_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/00002508-199703000-00003","volume":"13","author":"American Academy of Pain Medicine, American Pain Society","year":"1997","unstructured":"American Academy of Pain Medicine, American Pain Society: The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 1997, 13:6\u20138.","journal-title":"Clin J Pain"},{"key":"66_CR6","unstructured":"Federation of State Medical Boards of the United States, Inc: Model guidelines for the use of controlled substances for the treatment of pain. Available at http:\/\/www.fsmb.org. Accessed September 12, 2001. This document describes what medical boards legally require for opioid prescriptions written for the management of non-cancer pain. The majority of state medical boards have adopted these standards. The legality and propriety of using opioids for pain such as that seen in OA is clearly defined by this document."},{"key":"66_CR7","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1016\/0885-3924(90)90047-N","volume":"5","author":"RK Portenoy","year":"1990","unstructured":"Portenoy RK: Chronic opioid therapy for nonmalignant pain. J Pain Symptom Manage 1990, 5:S46-S62.","journal-title":"J Pain Symptom Manage"},{"key":"66_CR8","first-page":"1","volume":"2","author":"DC Turk","year":"1992","unstructured":"Turk DC, Brody MC: What position do APS\u2019s physician members take on chronic opioid therapy. APS Bull 1992, 2:1\u20135.","journal-title":"APS Bull"},{"key":"66_CR9","unstructured":"Grahmann P, Lipman AG, Jackson KC: Analysis of pain clinicians\u2019 perceptions of opioid use in chronic nonmalignant pain. Abstracts of the American Pain Society 19th Annual Scientific Meeting, 1999."},{"key":"66_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0885-3924(92)90116-Y","volume":"7","author":"M Zenz","year":"1992","unstructured":"Zenz M, Strumpf M, Tryba M: Long-term oral opioid therapy in patients with chronic nonmalignant pain. J Pain Symptom Manage 1992, 7:69\u201377.","journal-title":"J Pain Symptom Manage"},{"key":"66_CR11","first-page":"225","volume":"19","author":"RN Jamison","year":"1994","unstructured":"Jamison RN, Anderson KO, Peters-Asdourian C, Ferrante FM:Survey of opioid use in chronic nonmalignant pain patients. Reg Anesth 1994, 19:225\u2013230.","journal-title":"Reg Anesth"},{"key":"66_CR12","volume-title":"Management of cancer pain. Clinical practice guideline. AHCPR Publication Number 94-0592","author":"A Jacox","year":"1994","unstructured":"Jacox A, Carr DB, Payne R, et al.: Management of cancer pain. Clinical practice guideline. AHCPR Publication Number 94-0592. Rockville, MD: Agency for Health Care Policy and Research, US Department of Health and Human Services, Public Health Service; 1994."},{"key":"66_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0885-3924(95)00165-4","volume":"11","author":"SA Dunbar","year":"1996","unstructured":"Dunbar SA, Katz NP: Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse. J Pain Symptom Manage 1996, 11:163\u2013171.","journal-title":"J Pain Symptom Manage"},{"key":"66_CR14","first-page":"723","volume":"9","author":"PM Brooks","year":"1982","unstructured":"Brooks PM, Dougan MA, Mugford S, Meffin E: Comparative effectiveness of 5 analgesics in patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 1982, 9:723\u2013726.","journal-title":"J Rheumatol"},{"key":"66_CR15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5694\/j.1326-5377.1984.tb104004.x","volume":"140","author":"H Mitchell","year":"1984","unstructured":"Mitchell H, Cunningham TJ, Mathews JD, Muirden KD: Further look at dextropropoxyphene with or without paracetamol in the treatment of arthritis. Med J Australia 1984, 140:224\u2013225.","journal-title":"Med J Australia"},{"key":"66_CR16","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/j.1552-4604.1992.tb03800.x","volume":"32","author":"C Boissier","year":"1992","unstructured":"Boissier C, Perpoint B, Laporte-Simitsidis S, et al.: Acceptability and efficacy of two associations of paracetamol with a central analgesic (dextropropoxyphene or codeine): comparison in osteoarthritis. J Clin Pharmacol 1992, 32:990\u2013995.","journal-title":"J Clin Pharmacol"},{"key":"66_CR17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1185\/03007999209115221","volume":"13","author":"RS Lloyd","year":"1992","unstructured":"Lloyd RS, Costello F, Eves MJ, et al.: The efficacy and tolerability of controlled-release dihydrocodeine tablets and combination dextropropoxyphene paracetamol tablets in patients with severe osteoarthritis of the hips. Curr Med Res Opin 1992, 13:37\u201348.","journal-title":"Curr Med Res Opin"},{"key":"66_CR18","first-page":"179","volume":"4","author":"W Doak","year":"1992","unstructured":"Doak W, Hosie J, Hossain M, et al.: A novel combination of ibuprofen and codeine phosphate in the treatment of osteoarthritis: a double-blind placebo controlled study. J Drug Develop 1992, 4:179\u2013187.","journal-title":"J Drug Develop"},{"key":"66_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0304-3959(92)90035-A","volume":"50","author":"H Quiding","year":"1992","unstructured":"Quiding H, Grimstad J, Rusten K, et al.: Ibuprofen plus codeine, ibuprofen, and placebo in a single- and multidose cross-over comparison for coxarthrosis pain. Pain 1992, 50:303\u2013307.","journal-title":"Pain"},{"key":"66_CR20","first-page":"123","volume":"17","author":"F Boureau","year":"1991","unstructured":"Boureau F, Boccard E: Placebo-controlled study of the analgesic efficacy of a combination of paracetamol and codeine in rheumatoid arthritis. Acta Therapeutica 1991, 17:123\u2013136.","journal-title":"Acta Therapeutica"},{"key":"66_CR21","first-page":"764","volume":"27","author":"PM Peloso","year":"2000","unstructured":"Peloso PM, Bellamy N, Bensen W, et al.: Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee. J Rheumatol 2000, 27:764\u2013771.","journal-title":"J Rheumatol"},{"key":"66_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0304-3959(90)90028-C","volume":"43","author":"P Kjaersgaard-Andersen","year":"1990","unstructured":"Kjaersgaard-Andersen P, Nafei A, Skov O, et al.: Codeine plus paracetamol versus paracetamol in longer-term treatment of chronic pain due to osteoarthritis of the hip. A randomised, double-blind, multi-centre study. Pain 1990, 43:309\u2013318.","journal-title":"Pain"},{"key":"66_CR23","first-page":"41","volume":"20","author":"F Boureau","year":"1990","unstructured":"Boureau F, Delecoeuillerie G, Orvain J: Comparative study of the efficacy and tolerance of 2 dosages of the paracetamol 400 mg codeine 25 mg association versus paracetamol 1000 mg in non-inflammatory rheumatic pain. Rhumatologie Revue International de Rhumatologie 1990, 20:41\u201347.","journal-title":"Rhumatologie Revue International de Rhumatologie"},{"key":"66_CR24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1185\/03007999209115221","volume":"13","author":"RS Lloyd","year":"1992","unstructured":"Lloyd RS, Costello F, Eves MJ, et al.: The efficacy and tolerability of controlled-release dihydrocodeine tablets and combination dextropropoxyphene paracetamol tablets in patients with severe osteoarthritis of the hips. Curr Med Res Opin 1992, 13:37\u201348.","journal-title":"Curr Med Res Opin"},{"key":"66_CR25","volume-title":"Principles and Practice of Pain Medicine","author":"AG Lipman","year":"2002","unstructured":"Lipman AG, Jackson KC: Opioids. In Principles and Practice of Pain Medicine, edn 2. Edited by Warfield C, Bajwa Z. New York: McGraw Hill; 2002.","edition":"edn 2"},{"key":"66_CR26","first-page":"199","volume":"4","author":"IGV James","year":"1993","unstructured":"James IGV, Miller AJ, Baker H, et al.: A combination of ibuprofen and codeine phosphate in the management of osteoarthritis: a double blind comparison with ibuprofen. Br J Clin Res 1993, 4:199\u2013210.","journal-title":"Br J Clin Res"},{"key":"66_CR27","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1177\/107385840100700307","volume":"7","author":"GW Pasternak","year":"2001","unstructured":"Pasternak GW: The pharmacology of mu analgesics: from patients to genes. Neuroscientist 2001, 7:220\u2013231. The discovery of multiple mu1 opioid receptor subsets provides an explanation for interpatient variability in response to opioids. Failure of one opioid to provide adequate analgesia at an acceptable dose does not indicate \"opioid-resistant\" pain. Other opioids can and should be tried.","journal-title":"Neuroscientist"},{"key":"66_CR28","first-page":"862","volume":"26","author":"JR Caldwell","year":"1999","unstructured":"Caldwell JR, Hale ME, Boyd RE, et al.: Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial. J Rheumatol 1999, 26:862\u2013869. This randomized, controlled study documents the usefulness of oxycodone in the management of OA pain. Controlled release oxycodone and combinations of immediate release oxycodone and acetaminophen were effective.","journal-title":"J Rheumatol"},{"key":"66_CR29","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1001\/archinte.160.6.853","volume":"160","author":"SH Roth","year":"2000","unstructured":"Roth SH, Fleischmann RM, Burch FX, et al.: Around-the-clock, controlled-release oxycodone therapy for osteoarthritisrelated pain: placebo-controlled trial and long-term evaluation. Arch Intern Med 2000, 160:853\u2013860. This placebo-controlled study demonstrates the usefulness of controlled release oxycodone in OA pain over an extended period of time. Analgesia was maintained at a consistent dose with minimal adverse effects.","journal-title":"Arch Intern Med"},{"key":"66_CR30","unstructured":"American Pain Society: Definitions related to the use of opioids for the treatment of pain: a consensus document from the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine. Available at http:\/\/www.ampainsoc.org. Accessed September 12, 2001. Addiction, dependence, and tolerance are often misunderstood and feared unnecessarily. These definitions clarify and differentiate the three phenomena."},{"key":"66_CR31","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1001\/jama.259.4.555","volume":"259","author":"RC Rinaldi","year":"1988","unstructured":"Rinaldi RC, Steindler EM, Wilford BB, Goodman D:Clarification and standardization of substance abuse terminology. JAMA 1988, 259:555\u2013557.","journal-title":"JAMA"},{"key":"66_CR32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1300\/J251v05n01_11","volume":"5","author":"JP Morgan","year":"1985","unstructured":"Morgan JP: American opiophobia: customary underutilization of opioid analgesics. Adv Alcohol Subst Abuse 1985, 5:163\u2013173.","journal-title":"Adv Alcohol Subst Abuse"},{"key":"66_CR33","doi-asserted-by":"crossref","unstructured":"Bennett DS, Carr DB: Opiophobia as a barrier to the treatment of pain. J Pain Palliat Care Pharmacother 2002, 16 In press.","DOI":"10.1080\/J354v16n01_09"},{"key":"66_CR34","first-page":"123","volume":"302","author":"J Porter","year":"1980","unstructured":"Porter J, Jick H: Addiction rare in patients treated with narcotics. Letter. N Engl J Med 1980, 302:123.","journal-title":"N Engl J Med"},{"key":"66_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0304-3959(82)90016-1","volume":"13","author":"S Perry","year":"1982","unstructured":"Perry S, Heidrich G: Management of pain during debridement: a survey of U.S. pain units. Pain 1982, 13:267\u2013280.","journal-title":"Pain"},{"key":"66_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1526-4610.1977.hed1701012.x","volume":"17","author":"JL Medina","year":"1977","unstructured":"Medina JL, Diamond S: Drug dependency in patients with chronic headache. Headache 1977, 17:12\u201314.","journal-title":"Headache"},{"key":"66_CR37","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0304-3959(89)90097-3","volume":"36","author":"DE Weissman","year":"1989","unstructured":"Weissman DE, Haddox DJ: Opioid pseudoaddiction, an iatrogenic syndrome. Pain 1989, 36:363\u2013366. This classic paper describes how prescribing inadequate doses of opioids for pain management can lead to an appearance of substance abuse disorder, when the patient is simply seeking relief of pain. In 1997, this concept was accepted and endorsed by the American Society of Addiction Medicine.","journal-title":"Pain"},{"key":"66_CR38","first-page":"577","volume":"4","author":"BD Hare","year":"1990","unstructured":"Hare BD, Lipman AG: Uses and misuses of medication in chronic, noncancer pain. Probl Anesth 1990, 4:577\u2013594.","journal-title":"Probl Anesth"},{"key":"66_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1300\/J088v06n02_07","volume":"6","author":"M Pappagallo","year":"1998","unstructured":"Pappagallo M: The concept of pseudotolerance to opioids. J Pharmacol Care Pain Symptom Control 1998, 6:95\u201398. Once a few days of consistent analgesia have been achieved with a consistent opioid dose, most dose increases result from factors other than tolerance. Progressive disease, new pathology, excessive physical activity, skipping doses, drug interaction, and other occurrences usually explain the outcome. Tolerance is not a limiting factor to clinical use of opioids for chronic pain management.","journal-title":"J Pharmacol Care Pain Symptom Control"},{"key":"66_CR40","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1046\/j.1440-1681.2000.03293.x","volume":"27","author":"P Ravenscroft","year":"2000","unstructured":"Ravenscroft P, Schneider J: Bedside perspectives on the use of opioids: transferring results of clinical research into practice. Clin Exp Pharmacol Physiol 2000, 27:529\u2013532.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"66_CR41","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0885-3924(96)00011-5","volume":"11","author":"NP Sykes","year":"1996","unstructured":"Sykes NP: A volunteer model for the comparison of laxatives in opioid-related constipation. J Pain Symptom Manage 1996, 11:363\u2013369.","journal-title":"J Pain Symptom Manage"},{"key":"66_CR42","first-page":"1358","volume":"25","author":"SH Roth","year":"1998","unstructured":"Roth SH: Efficacy and safety of tramadol HCl in breakthrough musculoskeletal pain attributed to osteoarthritis. J Rheumatol 1998, 25:1358\u20131363.","journal-title":"J Rheumatol"},{"key":"66_CR43","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2165\/00044011-199816060-00002","volume":"16","author":"K Pavelka","year":"1998","unstructured":"Pavelka K, Peliskova Z, Stehlikova H, Ratcliffe S, Repas C:Intraindividual differences in pain relief and functional improvement in osteoarthritis with diclofenac or tramadol. Clin Drug Invest 1998, 16:421\u2013429.","journal-title":"Clin Drug Invest"},{"key":"66_CR44","first-page":"1","volume":"12","author":"H Van Cauwenberge","year":"1992","unstructured":"Van Cauwenberge H, Ruhwiedel M, Albert A, Franchimont P:Comparative study of tilidine-naloxone and pentazocine in knee and hip osteoarthritis. Int J Clin Pharmacol Res 1992, 12:1\u20139.","journal-title":"Int J Clin Pharmacol Res"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-001-0066-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-001-0066-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-001-0066-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-001-0066-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T10:16:14Z","timestamp":1652609774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-001-0066-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["66"],"URL":"https:\/\/doi.org\/10.1007\/s11926-001-0066-6","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}